N-[3-[6-(diethylamino)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-ynamide;N-[3-[6-(2-phenylethyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-(6-phenylpyrazin-2-yl)benzimidazol-5-yl]prop-2-enamide

C98H94N26O5 — CID 158395067

IUPACN-[3-[6-(diethylamino)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-ynamide;N-[3-[6-(2-phenylethyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-(6-phenylpyrazin-2-yl)benzimidazol-5-yl]prop-2-enamide
SMILESC#CC(=O)Nc1ccc2ncn(-c3cncc(CC(C)(C)C)n3)c2c1.C=CC(=O)Nc1ccc2ncn(-c3cc(CCc4ccccc4)ncn3)c2c1.C=CC(=O)Nc1ccc2ncn(-c3cc(N(CC)CC)ncn3)c2c1.C=CC(=O)Nc1ccc2ncn(-c3cncc(-c4ccccc4)n3)c2c1.C=CC(=O)Nc1ccc2ncn(-c3cncc(CC(C)(C)C)n3)c2c1
InChIInChI=1S/C22H19N5O.C20H15N5O.C19H21N5O.C19H19N5O.C18H20N6O/c1-2-22(28)26-18-10-11-19-20(12-18)27(15-25-19)21-13-17(23-14-24-21)9-8-16-6-4-3-5-7-16;1-2-20(26)23-15-8-9-16-18(10-15)25(13-22-16)19-12-21-11-17(24-19)14-6-4-3-5-7-14;2*1-5-18(25)23-13-6-7-15-16(8-13)24(12-21-15)17-11-20-10-14(22-17)9-19(2,3)4;1-4-18(25)22-13-7-8-14-15(9-13)24(12-21-14)17-10-16(19-11-20-17)23(5-2)6-3/h2-7,10-15H,1,8-9H2,(H,26,28);2-13H,1H2,(H,23,26);5-8,10-12H,1,9H2,2-4H3,(H,23,25);1,6-8,10-12H,9H2,2-4H3,(H,23,25);4,7-12H,1,5-6H2,2-3H3,(H,22,25)
InChIKeyGXLHCSCJCCZBIM-UHFFFAOYSA-N
MW1716.01 g/mol
LogP16.62
Rot. Bonds23

About N-[3-[6-(diethylamino)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-ynamide;N-[3-[6-(2-phenylethyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-(6-phenylpyrazin-2-yl)benzimidazol-5-yl]prop-2-enamide

N-[3-[6-(diethylamino)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-ynamide;N-[3-[6-(2-phenylethyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-(6-phenylpyrazin-2-yl)benzimidazol-5-yl]prop-2-enamide (PubChem CID 158395067) has the molecular formula C98H94N26O5 and a molecular weight of 1716.01 g/mol. Its IUPAC name is N-[3-[6-(diethylamino)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-ynamide;N-[3-[6-(2-phenylethyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-(6-phenylpyrazin-2-yl)benzimidazol-5-yl]prop-2-enamide.

Molecular Properties

Compound NameN-[3-[6-(diethylamino)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-ynamide;N-[3-[6-(2-phenylethyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-(6-phenylpyrazin-2-yl)benzimidazol-5-yl]prop-2-enamide
PubChem CID158395067
Molecular FormulaC98H94N26O5
Molecular Weight1716.01 g/mol
Exact Mass1714.79
IUPAC NameN-[3-[6-(diethylamino)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-ynamide;N-[3-[6-(2-phenylethyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-(6-phenylpyrazin-2-yl)benzimidazol-5-yl]prop-2-enamide
SMILESC#CC(=O)Nc1ccc2ncn(-c3cncc(CC(C)(C)C)n3)c2c1.C=CC(=O)Nc1ccc2ncn(-c3cc(CCc4ccccc4)ncn3)c2c1.C=CC(=O)Nc1ccc2ncn(-c3cc(N(CC)CC)ncn3)c2c1.C=CC(=O)Nc1ccc2ncn(-c3cncc(-c4ccccc4)n3)c2c1.C=CC(=O)Nc1ccc2ncn(-c3cncc(CC(C)(C)C)n3)c2c1
InChIInChI=1S/C22H19N5O.C20H15N5O.C19H21N5O.C19H19N5O.C18H20N6O/c1-2-22(28)26-18-10-11-19-20(12-18)27(15-25-19)21-13-17(23-14-24-21)9-8-16-6-4-3-5-7-16;1-2-20(26)23-15-8-9-16-18(10-15)25(13-22-16)19-12-21-11-17(24-19)14-6-4-3-5-7-14;2*1-5-18(25)23-13-6-7-15-16(8-13)24(12-21-15)17-11-20-10-14(22-17)9-19(2,3)4;1-4-18(25)22-13-7-8-14-15(9-13)24(12-21-14)17-10-16(19-11-20-17)23(5-2)6-3/h2-7,10-15H,1,8-9H2,(H,26,28);2-13H,1H2,(H,23,26);5-8,10-12H,1,9H2,2-4H3,(H,23,25);1,6-8,10-12H,9H2,2-4H3,(H,23,25);4,7-12H,1,5-6H2,2-3H3,(H,22,25)
InChIKeyGXLHCSCJCCZBIM-UHFFFAOYSA-N
XLogP16.62
TPSA366.74 Ų
H-Bond Donors5
H-Bond Acceptors26
Rotatable Bonds23
Heavy Atoms129
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001716.01
LogP ≤ 516.62
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze N-[3-[6-(diethylamino)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-ynamide;N-[3-[6-(2-phenylethyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-(6-phenylpyrazin-2-yl)benzimidazol-5-yl]prop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[3-[6-(diethylamino)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-ynamide;N-[3-[6-(2-phenylethyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-(6-phenylpyrazin-2-yl)benzimidazol-5-yl]prop-2-enamide?
The IUPAC name of N-[3-[6-(diethylamino)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-ynamide;N-[3-[6-(2-phenylethyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-(6-phenylpyrazin-2-yl)benzimidazol-5-yl]prop-2-enamide (CID 158395067) is N-[3-[6-(diethylamino)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-ynamide;N-[3-[6-(2-phenylethyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-(6-phenylpyrazin-2-yl)benzimidazol-5-yl]prop-2-enamide.
What is the SMILES notation for N-[3-[6-(diethylamino)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-ynamide;N-[3-[6-(2-phenylethyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-(6-phenylpyrazin-2-yl)benzimidazol-5-yl]prop-2-enamide?
The canonical SMILES for N-[3-[6-(diethylamino)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-ynamide;N-[3-[6-(2-phenylethyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-(6-phenylpyrazin-2-yl)benzimidazol-5-yl]prop-2-enamide is C#CC(=O)Nc1ccc2ncn(-c3cncc(CC(C)(C)C)n3)c2c1.C=CC(=O)Nc1ccc2ncn(-c3cc(CCc4ccccc4)ncn3)c2c1.C=CC(=O)Nc1ccc2ncn(-c3cc(N(CC)CC)ncn3)c2c1.C=CC(=O)Nc1ccc2ncn(-c3cncc(-c4ccccc4)n3)c2c1.C=CC(=O)Nc1ccc2ncn(-c3cncc(CC(C)(C)C)n3)c2c1.
What is the InChIKey of N-[3-[6-(diethylamino)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-ynamide;N-[3-[6-(2-phenylethyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-(6-phenylpyrazin-2-yl)benzimidazol-5-yl]prop-2-enamide?
The InChIKey is GXLHCSCJCCZBIM-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H19N5O.C20H15N5O.C19H21N5O.C19H19N5O.C18H20N6O/c1-2-22(28)26-18-10-11-19-20(12-18)27(15-25-19)21-13-17(23-14-24-21)9-8-16-6-4-3-5-7-16;1-2-20(26)23-15-8-9-16-18(10-15)25(13-22-16)19-12-21-11-17(24-19)14-6-4-3-5-7-14;2*1-5-18(25)23-13-6-7-15-16(8-13)24(12-21-15)17-11-20-10-14(22-17)9-19(2,3)4;1-4-18(25)22-13-7-8-14-15(9-13)24(12-21-14)17-10-16(19-11-20-17)23(5-2)6-3/h2-7,10-15H,1,8-9H2,(H,26,28);2-13H,1H2,(H,23,26);5-8,10-12H,1,9H2,2-4H3,(H,23,25);1,6-8,10-12H,9H2,2-4H3,(H,23,25);4,7-12H,1,5-6H2,2-3H3,(H,22,25).
What are the key properties of N-[3-[6-(diethylamino)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-ynamide;N-[3-[6-(2-phenylethyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-(6-phenylpyrazin-2-yl)benzimidazol-5-yl]prop-2-enamide?
N-[3-[6-(diethylamino)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-ynamide;N-[3-[6-(2-phenylethyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-(6-phenylpyrazin-2-yl)benzimidazol-5-yl]prop-2-enamide has a molecular weight of 1716.01 g/mol, XLogP of 16.62, 23 rotatable bonds, 5 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[6-(diethylamino)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-ynamide;N-[3-[6-(2-phenylethyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-(6-phenylpyrazin-2-yl)benzimidazol-5-yl]prop-2-enamide is sourced from PubChem (CID 158395067), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).